首页> 外文OA文献 >Efficacy and safety of short-term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis of randomized controlled trials

【2h】

Efficacy and safety of short-term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis of randomized controlled trials

机译：短期双抗血小板治疗（≤6个月）经皮冠状动脉综合征经皮冠状动脉综合征后的疗效和安全性：随机对照试验的系统审查和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Naoki Misumida; Mohamed Abo-Aly; Sun Moon Kim; Gbolahan O. Ogunbayo; Ahmed Abdel-Latif; Khaled M. Ziada;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet Therapy after percutaneous coronary intervention in patients with acute coronary syndromes ( SMART-DATE) prospective multicenter randomized trial [J] . Lee Joo Myung, Cho Deok-Kyu, Hahn Joo-Yong, The American heart journal . 2016,第期

机译：急性冠状动脉综合征患者经皮冠状动脉干预后6个月持续时间持续时间：理论与设计急性冠状动脉患者急性冠状动脉经皮冠状动脉介入后6个月持续时间急性血管成形术研究团队 - 安全性综合征（智能日期）预期多中心随机试验
2. Efficacy and safety of short‐term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta‐analysis of randomized controlled trials [J] . Naoki Misumida, Mohamed Abo‐Aly, Sun Moon Kim, Clinical cardiology. . 2018,第11期

机译：经皮冠状动脉介入治疗后短期双重抗血小板治疗（≤6个月）对急性冠脉综合征的疗效和安全性：随机对照试验的系统评价和荟萃分析
3. Abbreviated Dual Antiplatelet Therapy Followed by P2Y(12)Inhibitor Monotherapy versus 12 Months' Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Controlled Trials [J] . Kumar Ashish, Shariff Mariam, Doshi Rajkumar, American journal of cardiovascular drugs: drugs, devices, and other interventions . 2020,第4期

机译：缩写双抗血小板疗法，其次是P2Y（12）抑制剂单疗法与12个月的双抗血小板治疗术后经皮冠状动脉干预后：随机对照试验的系统审查和荟萃分析
4. Outcomes of Medical and Interventional Therapy in Elderly Patients with Acute Coronary Syndromes [C] . D.A. Halon, I. Dobrecky-Mery, S. Adawi, International Congress on Coronary Artery Disease . 2003

机译：老年急性冠状动脉综合征的老年患者的医疗和介入治疗结果
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Efficacy and safety of short‐term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta‐analysis of randomized controlled trials [O] . Naoki Misumida, Mohamed Abo‐Aly, Sun Moon Kim, 2018

机译：经皮冠状动脉介入治疗对急性冠脉综合征的短期双重抗血小板治疗（≤6个月）的有效性和安全性：随机对照试验的系统评价和荟萃分析
7. Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials [O] . Daniele Giacoppo, Yuji Matsuda, Luca Nai Fovino, 2020

机译：短双抗血小板疗法，其次是P2Y12抑制剂单疗法与第二代药洗脱支架经皮冠状动脉干预后的延长双抗血小板治疗：随机临床试验的系统评价和荟萃分析

Efficacy and safety of short-term dual antiplatelet therapy (≤6 months) after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis of randomized controlled trials

著录项

引文网络

相似文献

相关主题

期刊订阅